0.4278

25.74% 0.0876

Pre-market: .41 -0.0178 -4.15%

Collplant Biotechnologies Ltd (CLGN)

Overview News Price History Option Chain Discussions Forecast

Collplant Biotechnologies Ltd stock is traded at $0.4278, with a volume of 96,478. It is up +25.74% in the last 24 hours and up +15.30% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Previous Close:

$0.3402

Open:

$0.348

24h Volume:

96,478

Relative Volume:

1.03

Market Cap:

$6.17M

Revenue:

$389.00K

Net Income/Loss:

$-13.13M

P/E Ratio:

-0.4144

EPS:

-1.0323

Net Cash Flow:

$-11.90M

1W Performance:

+16.69%

1M Performance:

+15.30%

6M Performance:

-70.50%

1Y Performance:

-69.09%

1-Day Range:

$0.348

$0.43

1-Week Range:

$0.3037

$0.43

52-Week Range:

$0.2711

$3.2324

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name

Collplant Biotechnologies Ltd

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

Address

Employee

Twitter

@CollplantBio

Next Earnings Date

2026-08-19

Latest SEC Filings

CLGN's Discussions on Twitter

Compare CLGN vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLGN Collplant Biotechnologies Ltd	0.4278	5.03M	389.00K	-13.13M	-11.90M	-1.0323
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-17-23	Initiated	Alliance Global Partners	Buy

Collplant Biotechnologies Ltd Stock (CLGN) Latest News

Jul 01, 2026

CollPlant (Nasdaq: CLGN) raises $2.6M in share and warrant private deal - Stock Titan

Jul 01, 2026

Jun 30, 2026

CollPlant (CLGN) Secures $2.6 Million in Private Placement Offer - GuruFocus

Jun 30, 2026

CollPlant announces $2.6 million private placement By Investing.com - Investing.com Australia

Jun 30, 2026

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PR Newswire

Jun 30, 2026

Jun 29, 2026

CollPlant Biotechnologies Ltd. announced that it expects to receive $2.600001 million in funding - marketscreener.com

Jun 29, 2026

Jun 27, 2026

Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView

Jun 27, 2026

Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBIT forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView

Jun 26, 2026

Price to book forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView

Jun 26, 2026

Price to book forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView

Jun 26, 2026

Enterprise value to EBITDA forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView

Jun 26, 2026

Jun 25, 2026